Congress bans synthetic kratom compound, leaves plant legal
H.R. 8000 — END 7-OH Act · Filed by Gus Bilirakis (R-FL) · 8 cosponsors · Introduced Mar 19, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill adds synthetic 7-hydroxymitragynine to Schedule I of the Controlled Substances Act, making it illegal to manufacture, distribute, or possess. The bill explicitly exempts the naturally occurring compound found in kratom (Mitragyna speciosa), a plant-based substance currently legal. The effect is to ban the synthetic version while leaving the plant itself unscheduled.
Why we flagged it
The bill's sole operative function is to add a specific synthetic compound to the CSA Schedule I list. It is a narrow, technical amendment to drug law with no broader policy mechanism or rider.
What the text implies
- The exemption for naturally occurring 7-OH in kratom may create enforcement ambiguity: prosecutors and DEA must distinguish between synthetic and plant-derived forms, potentially leading to disputes over product composition and testing standards.
- Kratom vendors and users remain legal under this bill, but the synthetic ban may shift market demand toward the plant form, concentrating economic activity in the kratom industry without explicit subsidy or protection.
- The bill does not address existing synthetic 7-OH stockpiles or ongoing prescriptions/medical uses, if any; transition and grandfather provisions are absent, creating potential legal cliff for current users and sellers.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill restricts access to a psychoactive substance, which may reduce harms from synthetic drug use but also removes a legal option for consumers and eliminates a lawful market. The exemption for natural kratom preserves consumer choice for the plant form, but the synthetic ban narrows options and creates enforcement burden on users and small vendors.
Who stands to gain
- kratom vendors and suppliers (shift in consumer demand from synthetic to plant form)
Named in the bill
Controlled Substances Act, Schedule I, 7-hydroxymitragynine, Mitragyna speciosa, kratom, DEA, House Committee on the Judiciary
Where it stands
8 cosponsors: 8 Republicans.
- Mar 19, 2026 — Introduced · Congress.gov: “Introduced in House”
- Mar 19, 2026 — Referred to House Committee on the Judiciary and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $640,000 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 41% of bills with at least one filing.
Gus Bilirakis, the sponsor, reported $885,250 in PAC receipts in the 2026 cycle.
- Southern Poverty Law Center, Inc. — $480,000 on 1 filing
- Outpost Brands, LLC — $160,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (523 characters) on Sep 21, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 14,522 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-09-21.
“Congress bans synthetic kratom compound, leaves plant legal” QuorumCivic. https://share.quorumcivic.app/bill/119/hr8000 Report an error